Search clinical trials for: Antifungal Agents

Total 187146 results

Pfizer

Completed

Study Investigating Rapamune For Post-Marketing Surveillance

Kidney Transplantation

Korea, Republic of
Cliniques universitaires Saint-Luc- Université...

Completed

Efficacy and Safety of the Mammalian Target of Rapamycin (mTor Rapamycin) Inhibitor in Vascular Malformations (vasca-LM)

Cardiovascular Abnormalities

Belgium
The Cleveland Clinic
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Pilot Study of Rapamycin as Treatment for Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Polycystic Kidney Diseases

United States
Federation Francophone de Cancerologie Digestive

Terminated

Temsirolimus in Treating Patients With Advanced Liver Cancer and Cirrhosis

Liver Cancer

France
Taiwan Liposome Company

Completed

An Bioequivalence Study to Compare Two 2 mg/ml Liposomal Amphotericin B Injections in Healthy Subjects

Normal Healthy Subjects
Pfizer

Withdrawn

A Post Marketing Surveillance As Required By Philippine Food And Drug Administration

Renal Cell Carcinoma
Pfizer

Completed

Study Evaluating Biomarkers In Relapsed/Refractory Pediatric Solid Tumors

Neoplasms | Adenocarcinoma

United States, France, Russian Federation, Canada, Germany, Mexico, Poland
European Organisation for Research and Treatment...

Completed

Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients

Cancer

Belgium, Netherlands, Italy, Hungary, France, Spain, Germany, Israel, Czech Republic, United Arab Emirates, Sweden, Greece, Turkey, Portugal, Slovakia
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Rapamune in Transplant Recipients in the Nordic Countries

Transplantation

Sweden
Fudan University

Unknown

Sirolimus-Based Immunosuppression Therapy in OLT for Patients With HCC Exceeding Milan Criteria

Hepatocellular Carcinoma

China
Steven Hays, MD
OrphAI Therapeutics

Recruiting

LAM-001 in Lung Transplant Recipients With Bronchiolitis Obliterans Syndrome. (INSPO-BOS)

Lung Transplantation | Chronic Lung Allograft Dysfunction | Bronchiolitis Obliterans Syndrome

United States
Peking Union Medical College Hospital
North China Pharmaceutical Group Corporation

Not yet recruiting

Sirolimus in Treatment of Proteinuric Flares of Lupus Nephritis

Lupus Nephritis | Immunosuppression | Effect of Drug
University of Pennsylvania

Recruiting

Sirolimus in Previously Treated Idiopathic Multicentric Castleman Disease

Castleman Disease | Castleman's Disease, Multicentric

United States
Karolinska Institutet
Karolinska University Hospital

Enrolling by invitation

Evaluating Rapamycin Treatment in Alzheimer's Disease Using Positron Emission Tomography (ERAP)

Alzheimer Disease

Sweden
Institut Bergonié
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Phase II Evaluating Efficacy of Temsirolimus in 2 Line Therapy for Patients With Advanced Bladder Cancer (VESTOR)

Relapsed Bladder Cancer

France
Instituto de Oftalmología Fundación Conde de Valenciana

Completed

Liposomal Sirolimus in Dry Eye Disease

Dry Eye

Mexico
Peking Union Medical College Hospital
North-China Pharmaceutical Company, China

Unknown

The Efficacy and Safety of Sirolimus for Plastic Bronchitis

Plastic Bronchitis

China
Peking Union Medical College Hospital
Cancer Institute and Hospital, Chinese Academy of Medical Sciences; Air Force...

Unknown

Efficacy of Rapamycin (Sirolimus) in the Treatment of Peutz-Jeghers Syndrome

Peutz-Jeghers Syndrome

China
Medical University of Vienna

Unknown

Pulsed Oral Sirolimus in Autosomal Dominant Polycystic Kidney Disease (RAP)

Polycystic Kidney, Type 1 Autosomal Dominant Disease | Polycystic Kidney, Type 2 Autosomal Dominant Disease

Austria
Memorial Sloan Kettering Cancer Center
Pfizer; University of Wisconsin, Madison; Duke University; AEterna Zentaris; NATL...

Completed

Perifosine With Temsirolimus for Recurrent Pediatric Solid Tumors

Pediatric Solid Tumors

United States
City of Hope Medical Center
National Cancer Institute (NCI)

Completed

CCI-779 in Treating Patients With Metastatic Melanoma

Melanoma (Skin)

United States, Canada
Dr. Reddy's Laboratories Limited

Completed

Bioavailability Study of Sirolimus Tablets 2 mg Under Fasting Condition

Healthy

India
Pediatric Nephrology of Alabama
Pfizer; The Emmes Company, LLC

Completed

Calcineurin Inhibitor Based Immunosuppression Withdrawal (CNI-W)

Renal Transplant

United States
University of Alberta

Completed

De Novo Sirolimus-based Immunosuppression After Liver Transplantation for Hepatocellular Carcinoma

Liver Carcinoma

Canada
University of Tennessee Cancer Institute
Wyeth is now a wholly owned subsidiary of Pfizer

Unknown

Temsirolimus as Second-line Therapy in HCC

Unresectable or Metastatic Hepatocellular Carcinoma

United States
The University of Texas Health Science Center at...
National Cancer Institute (NCI); Wyeth is now a wholly owned subsidiary of... and other collaborators

Completed

CCI-779 in Treating Patients With Advanced Solid Tumors

Brain and Central Nervous System Tumors | Unspecified Adult Solid Tumor, Protocol Specific | Metastatic Cancer

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Sirolimus (Rapamune™) in Solid Organ Transplant Recipients

Kidney Transplantation | Graft vs Host Disease

Canada, United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

An Open Label Exploratory Study in Newly Diagnosed Prostate Cancer Patients

Prostatic Neoplasms

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Temsirolimus in Advanced Stage Squamous Cell Carcinoma of the Head & Neck

Squamous Cell Carcinoma

United States
Children's Hospital Medical Center, Cincinnati
The LAM Foundation; Tuberous Sclerosis Alliance

Completed

Rapamycin Therapy for Patients With Tuberous Sclerosis Complex and Sporadic LAM

Tuberous Sclerosis | Lymphangioleiomyomatosis

United States
Hallux, Inc.

Active, not recruiting

To Evaluate Hallux Terbinafine Subungual Gel (HSG) in the Treatment of Onychomycosis

Onychomycosis of Toenail

United States
Transgene

Terminated

Study of TG6002 (VV TK-RR-FCU1) in Combination With 5-FC in Patients With Advanced Gastro-intestinal Tumors.

Colorectal Neoplasm | Digestive System Neoplasm

France, Spain, Belgium
Anaeropharma Science, Inc.

Suspended

Phase I/II Study of APS001F With Flucytosine and Maltose in Solid Tumors

Neoplasms | Cancer | Tumors

United States
Astellas Pharma Inc

Completed

Trial of Two Dosing Regimens of Micafungin Versus Caspofungin for the Treatment of Esophageal Candidiasis

Candidiasis, Oral

Argentina, South Africa, Brazil, Peru
Transgene

Completed

Trial of TG4023 Combined With Flucytosine in Liver Tumors

Hepatocellular Carcinoma

France
Taro Pharmaceuticals USA

Completed

Evaluate the Clinical Equivalence of Two Naftifine HCl 1% Creams in Patients With Interdigital Tinea Pedis

Tinea Pedis
Novartis Pharmaceuticals

Completed

Efficacy Safety, and Tolerability of Topical Terbinafine in Patients With Mild to Moderate Toenail Fungus of the Big Toenail

Onychomycosis

United States, France, Germany
Grupo de Estudio de Infecciones en Transplantados
Merck Sharp & Dohme LLC

Unknown

Prophylaxis With Caspofungin in High-Risk Liver Transplantation

Liver Transplantation | Fungal Infection

Spain
Argus Pharmaceuticals

Completed

Pharmacokinetics of Nystatin LF I.V. in Patients With Acquired Immune Deficiency Syndrome-Related Complex (ARC)

HIV Infections

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Two Different Sirolimus-based Immunosuppressive Regimens in Elderly Kidney Transplant Recipients

Graft Rejection | Kidney Failure | Aged
Fundacion Nacional de Dermatologia
Hospital Dermatologico de Jorochito; Ministerio de Salud de Bolivia, Programa... and other collaborators

Completed

Oral Miltefosine Plus Topical Paromomycin In American Cutaneous Leishmaniasis

Cutaneous Leishmaniasis, American

Bolivia
Fujian Shengdi Pharmaceutical Co., Ltd.

Not yet recruiting

A Trial of Intravenous HRS9432 in the Treatment of Subjects With Candidemia and/or Invasive Candidiasis

Patients With Candidemia and/or Invasive Candidiasis
Bristol-Myers Squibb

Completed

A Study to Assess the Effects on the Single-Dose Drug Levels of Mavacamten in Healthy Participants

Healthy Participants

United States
Pfizer

Completed

Efficacy and Safety Evaluation of AN2690 Topical Solution to Treat Onychomycosis of the Toenail

Onychomycosis of Toenails

United States
Merck Sharp & Dohme LLC

Completed

A 28 - 90 Days Study to Evaluate the Safety, Tolerability, and Efficacy of Caspofungin Injection as Empirical Therapy in Indian Adults With Persistent Fever and Neutropenia (0991-053)(COMPLETED)

Fungal Infection
Merz North America, Inc.

Completed

Pharmacokinetic Study of Pediatric Subjects With Tinea Cruris and Tinea Pedis

Tinea Pedis | Tinea Cruris

Honduras, United States, Dominican Republic
Pfizer

Terminated

An Evaluation Of The Effectiveness And Safety Of Anidulafungin Compared To Caspofungin For The Treatment Of Serious Fungal Infection Due To Candida In Patients With A Dysfunctional Immune System

Candidiasis | Fungemia | Neutropenia

Poland, Russian Federation, France, Bosnia and Herzegovina, Italy, Slovakia
Novartis Pharmaceuticals

Completed

Efficacy, Safety, and Tolerability of Topical Terbinafine in Patients With Mild to Moderate Toenail Fungus of the Big Toenail

Onychomycosis

United States, Canada, Iceland
Huashan Hospital

Not yet recruiting

Hemorrhagic Brainstem Cavernous Malformations Treatment With Sirolimus: a Single Centre, Randomised, Placebo-controlled Trial (CALM)

Cavernous Malformations | Brain Stem Hemorrhage

China
Cystetic Medicines, Inc.
DevPro Biopharma

Recruiting

Study to Assess Amphotericin B Cystetic for Inhalation (ABCI) Doses in Healthy Volunteers & People With Cystic Fibrosis (ABCI)

Cystic Fibrosis

Australia, New Zealand

Search clinical trials for: Antifungal Agents

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Slovakia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations